Log in
Enquire now
‌

US Patent 8349851 JAK kinase modulating compounds and methods of use thereof

Patent 8349851 was granted and assigned to Ambit Biosciences on January, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Ambit Biosciences
Ambit Biosciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
83498510
Patent Inventor Names
Sunny Abraham0
Mark W. Holladay0
Michael J. Hadd0
Qi Chao0
Eduardo Setti0
Gang Liu0
Date of Patent
January 8, 2013
0
Patent Application Number
127143230
Date Filed
February 26, 2010
0
Patent Primary Examiner
‌
Brian McDowell
0
Patent abstract

Provided herein are quinazoline compounds of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8349851 JAK kinase modulating compounds and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us